DNAJB6P7

Across TCGA pan-cancer cohorts, DNAJB6P7 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of DNAJB6P7’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where DNAJB6P7 RNA is repressed in tumor relative to normal tissue. In most cancer types DNAJB6P7 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA, BRCA, and COAD are the cancer types where DNAJB6P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DNAJB6P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.086	.003	8	view →
BRCA	Female	All	+0.186	.046	2	view →
COAD	All	All	+0.083	.019	2	view →
KIRP	Female	All	+0.147	.009	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

DNAJB6P7–THCA

Open the THCA breakdown →